Regulus Therapeutics Inc (RGLS)
2.25
-0.18
(-7.41%)
USD |
NASDAQ |
May 07, 16:00
2.25
0.00 (0.00%)
After-Hours: 18:02
Regulus Therapeutics Shares Outstanding: 65.47M for March 15, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
March 15, 2024 | 65.47M |
March 14, 2024 | 65.46M |
March 11, 2024 | 20.36M |
December 31, 2023 | 20.22M |
November 03, 2023 | 20.22M |
September 30, 2023 | 20.22M |
August 04, 2023 | 19.48M |
June 30, 2023 | 19.48M |
May 05, 2023 | 19.48M |
April 19, 2023 | 19.48M |
April 15, 2023 | 19.48M |
April 13, 2023 | 19.48M |
March 31, 2023 | 16.86M |
March 17, 2023 | 16.84M |
December 31, 2022 | 16.84M |
November 04, 2022 | 16.84M |
September 30, 2022 | 16.84M |
August 05, 2022 | 14.63M |
June 30, 2022 | 14.63M |
June 29, 2022 | 14.60M |
May 06, 2022 | 14.60M |
April 12, 2022 | 14.60M |
March 31, 2022 | 14.60M |
March 04, 2022 | 14.60M |
December 31, 2021 | 14.60M |
Date | Value |
---|---|
November 30, 2021 | 14.60M |
November 05, 2021 | 8.705M |
September 30, 2021 | 8.705M |
August 06, 2021 | 8.704M |
June 30, 2021 | 8.704M |
May 07, 2021 | 7.492M |
April 16, 2021 | 7.492M |
March 31, 2021 | 7.469M |
March 05, 2021 | 7.250M |
February 28, 2021 | 7.250M |
December 31, 2020 | 6.743M |
December 11, 2020 | 6.690M |
December 04, 2020 | 6.350M |
October 30, 2020 | 3.916M |
September 30, 2020 | 3.916M |
August 07, 2020 | 3.592M |
June 30, 2020 | 3.592M |
May 08, 2020 | 2.761M |
April 20, 2020 | 2.761M |
March 31, 2020 | 2.761M |
March 06, 2020 | 2.104M |
December 31, 2019 | 2.102M |
November 08, 2019 | 2.093M |
September 30, 2019 | 2.093M |
August 02, 2019 | 2.082M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
2.055M
Minimum
May 07 2019
65.47M
Maximum
Mar 15 2024
12.56M
Average
8.705M
Median
Sep 30 2021
Shares Outstanding Benchmarks
ACADIA Pharmaceuticals Inc | 164.77M |
ADMA Biologics Inc | 228.22M |
FibroGen Inc | 98.77M |
Protara Therapeutics Inc | 20.59M |
Amylyx Pharmaceuticals Inc | 67.78M |